WO2001056985A1 - Procede de cyclisation d'acides 4-amino-2-halogenobutyriques optiquement actifs - Google Patents
Procede de cyclisation d'acides 4-amino-2-halogenobutyriques optiquement actifs Download PDFInfo
- Publication number
- WO2001056985A1 WO2001056985A1 PCT/JP2001/000736 JP0100736W WO0156985A1 WO 2001056985 A1 WO2001056985 A1 WO 2001056985A1 JP 0100736 W JP0100736 W JP 0100736W WO 0156985 A1 WO0156985 A1 WO 0156985A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- acid
- optically active
- amino
- azetidine
- reaction
- Prior art date
Links
- 239000002253 acid Substances 0.000 title claims abstract description 34
- 238000000034 method Methods 0.000 title claims description 16
- 150000007513 acids Chemical class 0.000 title 1
- 230000003287 optical effect Effects 0.000 claims abstract description 59
- 238000004519 manufacturing process Methods 0.000 claims abstract description 12
- 150000001412 amines Chemical class 0.000 claims abstract description 9
- 229910000287 alkaline earth metal oxide Inorganic materials 0.000 claims abstract description 7
- 229910052799 carbon Inorganic materials 0.000 claims abstract description 6
- 125000004432 carbon atom Chemical group C* 0.000 claims abstract description 6
- 125000005843 halogen group Chemical group 0.000 claims abstract description 6
- 229910001860 alkaline earth metal hydroxide Inorganic materials 0.000 claims abstract description 5
- 238000007363 ring formation reaction Methods 0.000 claims description 23
- 239000000203 mixture Substances 0.000 claims description 13
- 239000002904 solvent Substances 0.000 claims description 13
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 claims description 12
- -1 diisopropyl pyramine Chemical compound 0.000 claims description 10
- JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical group CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 claims description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 8
- RKMGAJGJIURJSJ-UHFFFAOYSA-N 2,2,6,6-tetramethylpiperidine Chemical group CC1(C)CCCC(C)(C)N1 RKMGAJGJIURJSJ-UHFFFAOYSA-N 0.000 claims description 7
- CPLXHLVBOLITMK-UHFFFAOYSA-N Magnesium oxide Chemical group [Mg]=O CPLXHLVBOLITMK-UHFFFAOYSA-N 0.000 claims description 5
- 229910052788 barium Inorganic materials 0.000 claims description 4
- DSAJWYNOEDNPEQ-UHFFFAOYSA-N barium atom Chemical compound [Ba] DSAJWYNOEDNPEQ-UHFFFAOYSA-N 0.000 claims description 4
- 239000000395 magnesium oxide Substances 0.000 claims description 4
- 239000003960 organic solvent Substances 0.000 claims description 4
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical group [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims description 3
- 229910052801 chlorine Inorganic materials 0.000 claims description 3
- 125000001309 chloro group Chemical group Cl* 0.000 claims description 3
- 150000003335 secondary amines Chemical group 0.000 claims description 3
- 150000003512 tertiary amines Chemical class 0.000 claims description 3
- 229910000000 metal hydroxide Inorganic materials 0.000 claims description 2
- 150000004692 metal hydroxides Chemical class 0.000 claims description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical group [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 claims 1
- IADUEWIQBXOCDZ-UHFFFAOYSA-N azetidine-2-carboxylic acid Chemical compound OC(=O)C1CCN1 IADUEWIQBXOCDZ-UHFFFAOYSA-N 0.000 abstract description 9
- IADUEWIQBXOCDZ-VKHMYHEASA-N Azetidine-2-carboxylic acid Natural products OC(=O)[C@@H]1CCN1 IADUEWIQBXOCDZ-VKHMYHEASA-N 0.000 abstract description 6
- RQPZNWPYLFFXCP-UHFFFAOYSA-L barium dihydroxide Chemical compound [OH-].[OH-].[Ba+2] RQPZNWPYLFFXCP-UHFFFAOYSA-L 0.000 abstract description 5
- 229910001863 barium hydroxide Inorganic materials 0.000 abstract description 5
- 238000006243 chemical reaction Methods 0.000 description 36
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 30
- 239000000243 solution Substances 0.000 description 28
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 24
- DYHSDKLCOJIUFX-UHFFFAOYSA-N tert-butoxycarbonyl anhydride Chemical compound CC(C)(C)OC(=O)OC(=O)OC(C)(C)C DYHSDKLCOJIUFX-UHFFFAOYSA-N 0.000 description 15
- 239000007864 aqueous solution Substances 0.000 description 14
- 239000012044 organic layer Substances 0.000 description 11
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 10
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical class [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 9
- UAOMVDZJSHZZME-UHFFFAOYSA-N diisopropylamine Chemical compound CC(C)NC(C)C UAOMVDZJSHZZME-UHFFFAOYSA-N 0.000 description 9
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 8
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 239000002585 base Substances 0.000 description 6
- 238000002955 isolation Methods 0.000 description 6
- 239000011541 reaction mixture Substances 0.000 description 6
- 125000005931 tert-butyloxycarbonyl group Chemical group [H]C([H])([H])C(OC(*)=O)(C([H])([H])[H])C([H])([H])[H] 0.000 description 6
- GMTKEFXQMRVCOB-GSVOUGTGSA-N (2r)-4-amino-2-chlorobutanoic acid Chemical compound NCC[C@@H](Cl)C(O)=O GMTKEFXQMRVCOB-GSVOUGTGSA-N 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- JWJVSDZKYYXDDN-LURJTMIESA-N (2s)-1-[(2-methylpropan-2-yl)oxycarbonyl]azetidine-2-carboxylic acid Chemical compound CC(C)(C)OC(=O)N1CC[C@H]1C(O)=O JWJVSDZKYYXDDN-LURJTMIESA-N 0.000 description 4
- YBYIRNPNPLQARY-UHFFFAOYSA-N 1H-indene Chemical compound C1=CC=C2CC=CC2=C1 YBYIRNPNPLQARY-UHFFFAOYSA-N 0.000 description 4
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Chemical compound CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 4
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 4
- VLTRZXGMWDSKGL-UHFFFAOYSA-N perchloric acid Chemical compound OCl(=O)(=O)=O VLTRZXGMWDSKGL-UHFFFAOYSA-N 0.000 description 4
- 230000006340 racemization Effects 0.000 description 4
- 229910000029 sodium carbonate Inorganic materials 0.000 description 4
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 description 3
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 3
- DKGAVHZHDRPRBM-UHFFFAOYSA-N Tert-Butanol Chemical compound CC(C)(C)O DKGAVHZHDRPRBM-UHFFFAOYSA-N 0.000 description 3
- 238000004440 column chromatography Methods 0.000 description 3
- 229940043279 diisopropylamine Drugs 0.000 description 3
- 238000005342 ion exchange Methods 0.000 description 3
- VTHJTEIRLNZDEV-UHFFFAOYSA-L magnesium dihydroxide Chemical compound [OH-].[OH-].[Mg+2] VTHJTEIRLNZDEV-UHFFFAOYSA-L 0.000 description 3
- 239000000347 magnesium hydroxide Substances 0.000 description 3
- 229910001862 magnesium hydroxide Inorganic materials 0.000 description 3
- AXZKOIWUVFPNLO-UHFFFAOYSA-N magnesium;oxygen(2-) Chemical compound [O-2].[Mg+2] AXZKOIWUVFPNLO-UHFFFAOYSA-N 0.000 description 3
- ASNHGEVAWNWCRQ-UHFFFAOYSA-N 4-(hydroxymethyl)oxolane-2,3,4-triol Chemical compound OCC1(O)COC(O)C1O ASNHGEVAWNWCRQ-UHFFFAOYSA-N 0.000 description 2
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- ROSDSFDQCJNGOL-UHFFFAOYSA-N Dimethylamine Chemical compound CNC ROSDSFDQCJNGOL-UHFFFAOYSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- PCLIMKBDDGJMGD-UHFFFAOYSA-N N-bromosuccinimide Chemical compound BrN1C(=O)CCC1=O PCLIMKBDDGJMGD-UHFFFAOYSA-N 0.000 description 2
- UEEJHVSXFDXPFK-UHFFFAOYSA-N N-dimethylaminoethanol Chemical compound CN(C)CCO UEEJHVSXFDXPFK-UHFFFAOYSA-N 0.000 description 2
- GLUUGHFHXGJENI-UHFFFAOYSA-N Piperazine Chemical compound C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 description 2
- 150000003973 alkyl amines Chemical group 0.000 description 2
- 125000003277 amino group Chemical group 0.000 description 2
- 150000004982 aromatic amines Chemical group 0.000 description 2
- QVQLCTNNEUAWMS-UHFFFAOYSA-N barium oxide Chemical compound [Ba]=O QVQLCTNNEUAWMS-UHFFFAOYSA-N 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 238000002425 crystallisation Methods 0.000 description 2
- 230000008025 crystallization Effects 0.000 description 2
- JQVDAXLFBXTEQA-UHFFFAOYSA-N dibutylamine Chemical compound CCCCNCCCC JQVDAXLFBXTEQA-UHFFFAOYSA-N 0.000 description 2
- DMBHHRLKUKUOEG-UHFFFAOYSA-N diphenylamine Chemical compound C=1C=CC=CC=1NC1=CC=CC=C1 DMBHHRLKUKUOEG-UHFFFAOYSA-N 0.000 description 2
- 238000004128 high performance liquid chromatography Methods 0.000 description 2
- 239000012046 mixed solvent Substances 0.000 description 2
- 238000006386 neutralization reaction Methods 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 230000035484 reaction time Effects 0.000 description 2
- JWHOQZUREKYPBY-UHFFFAOYSA-N rubonic acid Natural products CC1(C)CCC2(CCC3(C)C(=CCC4C5(C)CCC(=O)C(C)(C)C5CC(=O)C34C)C2C1)C(=O)O JWHOQZUREKYPBY-UHFFFAOYSA-N 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- GETQZCLCWQTVFV-UHFFFAOYSA-N trimethylamine Chemical compound CN(C)C GETQZCLCWQTVFV-UHFFFAOYSA-N 0.000 description 2
- GMTKEFXQMRVCOB-VKHMYHEASA-N (2s)-4-amino-2-chlorobutanoic acid Chemical compound NCC[C@H](Cl)C(O)=O GMTKEFXQMRVCOB-VKHMYHEASA-N 0.000 description 1
- XULIXFLCVXWHRF-UHFFFAOYSA-N 1,2,2,6,6-pentamethylpiperidine Chemical compound CN1C(C)(C)CCCC1(C)C XULIXFLCVXWHRF-UHFFFAOYSA-N 0.000 description 1
- XGINAUQXFXVBND-UHFFFAOYSA-N 1,2,6,7,8,8a-hexahydropyrrolo[1,2-a]pyrimidine Chemical compound N1CC=CN2CCCC21 XGINAUQXFXVBND-UHFFFAOYSA-N 0.000 description 1
- 238000001644 13C nuclear magnetic resonance spectroscopy Methods 0.000 description 1
- SWKPGMVENNYLFK-UHFFFAOYSA-N 2-(dipropylamino)ethanol Chemical compound CCCN(CCC)CCO SWKPGMVENNYLFK-UHFFFAOYSA-N 0.000 description 1
- KXJIIWGGVZEGBD-UHFFFAOYSA-N 2-methyl-n,n-bis(2-methylphenyl)aniline Chemical compound CC1=CC=CC=C1N(C=1C(=CC=CC=1)C)C1=CC=CC=C1C KXJIIWGGVZEGBD-UHFFFAOYSA-N 0.000 description 1
- IIFFFBSAXDNJHX-UHFFFAOYSA-N 2-methyl-n,n-bis(2-methylpropyl)propan-1-amine Chemical compound CC(C)CN(CC(C)C)CC(C)C IIFFFBSAXDNJHX-UHFFFAOYSA-N 0.000 description 1
- WONYVCKUEUULQN-UHFFFAOYSA-N 2-methyl-n-(2-methylphenyl)aniline Chemical compound CC1=CC=CC=C1NC1=CC=CC=C1C WONYVCKUEUULQN-UHFFFAOYSA-N 0.000 description 1
- OWSRLHPWDZOHCR-UHFFFAOYSA-N 4,4-diaminobutanoic acid Chemical compound NC(N)CCC(O)=O OWSRLHPWDZOHCR-UHFFFAOYSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical group [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- BWLUMTFWVZZZND-UHFFFAOYSA-N Dibenzylamine Chemical compound C=1C=CC=CC=1CNCC1=CC=CC=C1 BWLUMTFWVZZZND-UHFFFAOYSA-N 0.000 description 1
- XBPCUCUWBYBCDP-UHFFFAOYSA-N Dicyclohexylamine Chemical compound C1CCCCC1NC1CCCCC1 XBPCUCUWBYBCDP-UHFFFAOYSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- OGNSCSPNOLGXSM-VKHMYHEASA-N L-2,4-diaminobutyric acid Chemical compound NCC[C@H](N)C(O)=O OGNSCSPNOLGXSM-VKHMYHEASA-N 0.000 description 1
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 description 1
- 238000005481 NMR spectroscopy Methods 0.000 description 1
- 241000594009 Phoxinus phoxinus Species 0.000 description 1
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 150000001340 alkali metals Chemical class 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- QZPSXPBJTPJTSZ-UHFFFAOYSA-N aqua regia Chemical compound Cl.O[N+]([O-])=O QZPSXPBJTPJTSZ-UHFFFAOYSA-N 0.000 description 1
- 150000003975 aryl alkyl amines Chemical group 0.000 description 1
- HONIICLYMWZJFZ-UHFFFAOYSA-N azetidine Chemical compound C1CNC1 HONIICLYMWZJFZ-UHFFFAOYSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 239000012267 brine Substances 0.000 description 1
- AXCZMVOFGPJBDE-UHFFFAOYSA-L calcium dihydroxide Chemical compound [OH-].[OH-].[Ca+2] AXCZMVOFGPJBDE-UHFFFAOYSA-L 0.000 description 1
- 239000000920 calcium hydroxide Substances 0.000 description 1
- 229910001861 calcium hydroxide Inorganic materials 0.000 description 1
- BRPQOXSCLDDYGP-UHFFFAOYSA-N calcium oxide Chemical compound [O-2].[Ca+2] BRPQOXSCLDDYGP-UHFFFAOYSA-N 0.000 description 1
- 239000000292 calcium oxide Substances 0.000 description 1
- ODINCKMPIJJUCX-UHFFFAOYSA-N calcium oxide Inorganic materials [Ca]=O ODINCKMPIJJUCX-UHFFFAOYSA-N 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 239000007810 chemical reaction solvent Substances 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- VAYGXNSJCAHWJZ-UHFFFAOYSA-N dimethyl sulfate Chemical compound COS(=O)(=O)OC VAYGXNSJCAHWJZ-UHFFFAOYSA-N 0.000 description 1
- 125000002147 dimethylamino group Chemical group [H]C([H])([H])N(*)C([H])([H])[H] 0.000 description 1
- LAWOZCWGWDVVSG-UHFFFAOYSA-N dioctylamine Chemical compound CCCCCCCCNCCCCCCCC LAWOZCWGWDVVSG-UHFFFAOYSA-N 0.000 description 1
- WEHWNAOGRSTTBQ-UHFFFAOYSA-N dipropylamine Chemical compound CCCNCCC WEHWNAOGRSTTBQ-UHFFFAOYSA-N 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 239000003480 eluent Substances 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 125000001153 fluoro group Chemical group F* 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 150000007529 inorganic bases Chemical class 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 150000004702 methyl esters Chemical class 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- KEEXPDPBIQJVKK-UHFFFAOYSA-N n,2-dimethyl-n-(2-methylpropyl)propan-1-amine Chemical compound CC(C)CN(C)CC(C)C KEEXPDPBIQJVKK-UHFFFAOYSA-N 0.000 description 1
- MXHTZQSKTCCMFG-UHFFFAOYSA-N n,n-dibenzyl-1-phenylmethanamine Chemical compound C=1C=CC=CC=1CN(CC=1C=CC=CC=1)CC1=CC=CC=C1 MXHTZQSKTCCMFG-UHFFFAOYSA-N 0.000 description 1
- OBYVIBDTOCAXSN-UHFFFAOYSA-N n-butan-2-ylbutan-2-amine Chemical compound CCC(C)NC(C)CC OBYVIBDTOCAXSN-UHFFFAOYSA-N 0.000 description 1
- PWONKOVIFVKASG-UHFFFAOYSA-N n-ethyl-2,4,4-trimethylpentan-2-amine Chemical compound CCNC(C)(C)CC(C)(C)C PWONKOVIFVKASG-UHFFFAOYSA-N 0.000 description 1
- NJWMENBYMFZACG-UHFFFAOYSA-N n-heptylheptan-1-amine Chemical compound CCCCCCCNCCCCCCC NJWMENBYMFZACG-UHFFFAOYSA-N 0.000 description 1
- PXSXRABJBXYMFT-UHFFFAOYSA-N n-hexylhexan-1-amine Chemical compound CCCCCCNCCCCCC PXSXRABJBXYMFT-UHFFFAOYSA-N 0.000 description 1
- JACMPVXHEARCBO-UHFFFAOYSA-N n-pentylpentan-1-amine Chemical compound CCCCCNCCCCC JACMPVXHEARCBO-UHFFFAOYSA-N 0.000 description 1
- CATWEXRJGNBIJD-UHFFFAOYSA-N n-tert-butyl-2-methylpropan-2-amine Chemical compound CC(C)(C)NC(C)(C)C CATWEXRJGNBIJD-UHFFFAOYSA-N 0.000 description 1
- 150000004689 octahydrates Chemical class 0.000 description 1
- 125000003367 polycyclic group Chemical group 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 150000003337 secondary aryl alkyl amines Chemical class 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- MFPWEWYKQYMWRO-UHFFFAOYSA-N tert-butyl carboxy carbonate Chemical compound CC(C)(C)OC(=O)OC(O)=O MFPWEWYKQYMWRO-UHFFFAOYSA-N 0.000 description 1
- IMFACGCPASFAPR-UHFFFAOYSA-N tributylamine Chemical compound CCCCN(CCCC)CCCC IMFACGCPASFAPR-UHFFFAOYSA-N 0.000 description 1
- RKBCYCFRFCNLTO-UHFFFAOYSA-N triisopropylamine Chemical compound CC(C)N(C(C)C)C(C)C RKBCYCFRFCNLTO-UHFFFAOYSA-N 0.000 description 1
- ODHXBMXNKOYIBV-UHFFFAOYSA-N triphenylamine Chemical compound C1=CC=CC=C1N(C=1C=CC=CC=1)C1=CC=CC=C1 ODHXBMXNKOYIBV-UHFFFAOYSA-N 0.000 description 1
- YFTHZRPMJXBUME-UHFFFAOYSA-N tripropylamine Chemical compound CCCN(CCC)CCC YFTHZRPMJXBUME-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
- C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
- C07D205/04—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
Definitions
- the present invention relates to a method for producing optically active azetidine-12-carboxylic acid, which is important as an intermediate for pharmaceuticals and the like, using a cyclization reaction of optically active 4-amino-2-logenobutyric acid.
- the following method is known as a conventional method for producing azetidine-12-carboxylic acid using a cyclization reaction of 4-amino-12-logenobutyric acid.
- the optical purity of the obtained product is significantly reduced due to the progress of the racemization of the optically active compound.
- one enantiomer is generally unnecessary, and therefore, for example, an operation for improving the optical purity by separation or the like is required, and Discards unless an advantageous racemization method is found This is not economical and therefore difficult to implement industrially.
- the obtained azetidine-12-carboxylic acid is in a racemic form, and in order to obtain an optically active form, an operation of resolving the racemic form is necessary.
- the separated enantiomers will be discarded unless an advantageous racemization method is found, so that they are not economical and are difficult to implement industrially.
- An object of the present invention is to provide a method for producing optically active azetidine-12-carboxylic acid, which is efficient, economical, and industrially suitable in view of the above situation. Things.
- the inventors of the present invention have conducted intensive studies to solve such problems, and as a result, have completed the present invention.
- the present invention provides a compound represented by the general formula (1):
- the present invention provides a method for producing an optically active azetidine 2-carbonic acid represented by the formula: A method for producing 2-rubic acid is provided.
- optically active 4-amino-2-halogenobutyric acid which is a starting material of the present invention, is a pure product of the (R) -isomer or the (S) -isomer of the enantiomer or of the enantiomer.
- a mixture of both enantiomers in which either of the enantiomers is present in excess may be used.
- the optical purity is high. Needless to say.
- halogen atom in the optically active 4-amino-2-halogenobutyric acid can be a fluorine atom, a chlorine atom, a bromine atom or an iodine atom, but a chlorine atom or a bromine atom is preferred.
- Such optically active 4-amino-2-halogenobutyric acid can be produced, for example, by the method described in Biochemical Journal, Vol. 64, p. 323 (1956), by the method described in (S) —2, From 4-diaminobutyric acid, it can be obtained as (S) -4-amino-2-butyric acid. Also, for example, according to the method described in Japanese Patent Application No. 1-169620, (R) _4-amino-12-halogenobutyrate is hydrolyzed in an aqueous solution of mineral acid, and (R) -4-amino- It can be obtained as a hydrolysis solution containing 2-halogenobutyric acid.
- the hydrolyzed solution can be used for the cyclization reaction as it is, for example, after neutralization with an alkali metal base.
- the neutralized solution is further purified by ion exchange column chromatography to obtain an optically active (R)- 4-Amino-2-halogenobutyric acid can also be isolated.
- the optically active 4-amino-2-halogenobutyric acid represented by the general formula (1) thus obtained is converted to an alkaline earth metal oxide, an alkaline earth metal hydroxide other than barium, or an organic amine.
- an optically active azetidine-12-carboxylic acid represented by the general formula (2) can be produced with a high optical yield.
- the alkaline earth metal oxide used in the cyclization reaction include magnesium oxide, calcium oxide, barium oxide, and the like. Of these, magnesium oxide is particularly preferred.
- Examples of the alkaline earth metal hydroxide include magnesium hydroxide and calcium hydroxide, and magnesium hydroxide is particularly preferred.
- a secondary amine or a tertiary amine is preferably used.
- diisopropylamine, 2 , 2,6,6-tetramethylpiperidine, triethylamine, diisopropylethylamine, 1,8-diazabicyclo [4.5.0] indene, N, N-dimethylethanolamine are preferred.
- the amount of the base to be used is not particularly limited, but is usually from 1 to 30 molar equivalents to the optically active 4-amino-2-halogenobutyric acid (1).
- the reaction can be carried out. Generally, it is preferable to use from 1 molar equivalent to 10 molar equivalents.
- a solvent is generally used in the above-mentioned cyclization reaction, and water or a mixed solvent of water and a water-soluble organic solvent arbitrarily miscible with water is preferably used.
- water-soluble organic solvents include methanol, ethanol, isopropinoleanol, tert-butyl alcohol, acetone, acetate nitrile, N, N-dimethylformamide, N, N-dimethylacetamide. These solvents are used in an amount of 1 to 100 volumes based on water. It can be used in a ratio of / 0 , but preferably 1 to 50 volumes. / 0 Good to use.
- the concentration of raw 4-amino-2-halogenobutyric acid (1) is generally 0.5 to 50% by weight. / 0 can be used to carry out the reaction, preferably:! ⁇ 3 0 weight. / 0 concentration.
- the reaction temperature at the time of the cyclization reaction varies depending on the type of the base used, but is usually in the range from the freezing point to the boiling point or lower of water as a reaction solvent or a mixed solvent of water and a water-soluble organic solvent. In order to complete the reaction in a short time, it is better to carry out the reaction at a higher temperature, and from the viewpoint of preventing racemization during the reaction, it is better to carry out the reaction at a lower temperature.
- reaction time of the cyclization reaction also depends on the type and equivalent of the base used and the reaction temperature, but for example, when the reaction is carried out at a temperature of 80 to 100 ° C, usually 20 minutes to 12 hours The reaction can be completed to a degree.
- the cyclization reaction can be carried out as described above.
- the cyclization reaction is a substitution-type cyclization involving stereochemical inversion of the halogen substituent at the 2-position in optically active 4-amino-12-halogenobutyric acid (1). It is a reaction, and the (S) -form produces (R) -form, and the (R) -form produces (S) -form of azetidine-12-caprolubinic acid. Also, by appropriately adjusting the reaction conditions, the optical yield of the cyclization reaction can be as high as 90% or more.
- the optical yield refers to the optical purity of the generated optically active azetidine-12-carboxylic acid relative to the optical purity (enantiomeric excess,% ee) of the optically active 4-amino-2-halogenobutyric acid as a raw material.
- the percentage of purity (enantiomeric excess,% ee) is expressed as a percentage.
- the cyclization reaction solution can be used for protecting the amino group without isolating the cyclization reaction product.
- it can be directly used and isolated as an optically active azetidine-12-carboxylic acid derivative having a protected amino group by a commonly used method such as extraction, concentration, chromatography, or crystallization.
- the yield was determined by high performance liquid chromatography using a high purity product of (S) -N- (tert-butoxycarbonyl) azetidine-121-rubric acid as a standard. Optical purity was measured using high performance liquid chromatography under the following conditions.
- cyclization of optically active 4-amino-2 logenobutyric acid in the presence of an alkaline earth metal oxide, an alkaline earth metal hydroxide other than barium, or an organic amine provides With a high optical yield of 0% or more, optically active azetidine-12-carboxylic acid can be produced efficiently, simply, and industrially advantageously.
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Catalysts (AREA)
- Plural Heterocyclic Compounds (AREA)
Description
Claims
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE60108355T DE60108355T2 (de) | 2000-02-04 | 2001-02-02 | Verfahren zur zyklisierung von optisch aktiven 4-amino-2-halogenbuttersäuren |
AU2001230569A AU2001230569A1 (en) | 2000-02-04 | 2001-02-02 | Process for cyclizing optically active 4-amino-2-halogenobutyric acids |
US10/182,649 US6747161B2 (en) | 2000-02-04 | 2001-02-02 | Process for cyclizing optically active 4-amino-2-halogenobutyric acids |
EP01902737A EP1253140B1 (en) | 2000-02-04 | 2001-02-02 | Process for cyclizing optically active 4-amino-2-halogenobutyric acids |
AT01902737T ATE286881T1 (de) | 2000-02-04 | 2001-02-02 | Verfahren zur zyklisierung von optisch aktiven 4- amino-2-halogenbuttersäuren |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2000-27909 | 2000-02-04 | ||
JP2000027909 | 2000-02-04 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2001056985A1 true WO2001056985A1 (fr) | 2001-08-09 |
Family
ID=18553414
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2001/000736 WO2001056985A1 (fr) | 2000-02-04 | 2001-02-02 | Procede de cyclisation d'acides 4-amino-2-halogenobutyriques optiquement actifs |
Country Status (8)
Country | Link |
---|---|
US (1) | US6747161B2 (ja) |
EP (1) | EP1253140B1 (ja) |
AT (1) | ATE286881T1 (ja) |
AU (1) | AU2001230569A1 (ja) |
DE (1) | DE60108355T2 (ja) |
ES (1) | ES2234802T3 (ja) |
TW (1) | TW506959B (ja) |
WO (1) | WO2001056985A1 (ja) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP3585422B2 (ja) * | 2000-06-01 | 2004-11-04 | シャープ株式会社 | アクセスポイント装置及びその認証処理方法 |
CN102241583A (zh) * | 2011-05-13 | 2011-11-16 | 嘉兴市博源生物化工科技有限公司 | 合成2-氯丁酸的方法 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000003982A1 (en) * | 1998-07-17 | 2000-01-27 | Astrazeneca Ab | Cyclisation process |
WO2000069817A1 (fr) * | 1999-05-14 | 2000-11-23 | Kaneka Corporation | Procede de production d'acides azetidine -2- carboxyliques optiquement actifs |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH10120648A (ja) * | 1996-10-23 | 1998-05-12 | Sumitomo Chem Co Ltd | 光学活性n置換アゼチジン−2−カルボン酸およびその製造方法 |
US6617461B2 (en) * | 2000-01-25 | 2003-09-09 | Kaneka Corporation | Process for preparation of optically active N-substituted azetidine-2-carboxylic acids |
-
2001
- 2001-02-02 AT AT01902737T patent/ATE286881T1/de not_active IP Right Cessation
- 2001-02-02 DE DE60108355T patent/DE60108355T2/de not_active Expired - Fee Related
- 2001-02-02 WO PCT/JP2001/000736 patent/WO2001056985A1/ja active IP Right Grant
- 2001-02-02 ES ES01902737T patent/ES2234802T3/es not_active Expired - Lifetime
- 2001-02-02 AU AU2001230569A patent/AU2001230569A1/en not_active Abandoned
- 2001-02-02 US US10/182,649 patent/US6747161B2/en not_active Expired - Fee Related
- 2001-02-02 TW TW090102122A patent/TW506959B/zh not_active IP Right Cessation
- 2001-02-02 EP EP01902737A patent/EP1253140B1/en not_active Expired - Lifetime
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000003982A1 (en) * | 1998-07-17 | 2000-01-27 | Astrazeneca Ab | Cyclisation process |
WO2000069817A1 (fr) * | 1999-05-14 | 2000-11-23 | Kaneka Corporation | Procede de production d'acides azetidine -2- carboxyliques optiquement actifs |
Non-Patent Citations (2)
Title |
---|
BIOCHEM. J., vol. 64, 1956, pages 323 - 332 * |
CHEMICAL ABSTRACTS, vol. 51, Columbus, Ohio, US; page 3547G; XP002941603 * |
Also Published As
Publication number | Publication date |
---|---|
US20030109719A1 (en) | 2003-06-12 |
DE60108355T2 (de) | 2005-06-16 |
ATE286881T1 (de) | 2005-01-15 |
AU2001230569A1 (en) | 2001-08-14 |
TW506959B (en) | 2002-10-21 |
EP1253140B1 (en) | 2005-01-12 |
US6747161B2 (en) | 2004-06-08 |
EP1253140A4 (en) | 2003-03-26 |
DE60108355D1 (de) | 2005-02-17 |
ES2234802T3 (es) | 2005-07-01 |
EP1253140A1 (en) | 2002-10-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR100879409B1 (ko) | (s)-베포타스틴의 제조방법 및 이에 사용되는 중간체 | |
RU2540076C2 (ru) | Способ получения производных 1-(2-галогенобифенил-4-ил)-циклопропанкарбоновой кислоты | |
US10370329B2 (en) | Process for the enantiomeric resolution of apremilast intermediates | |
US11198703B2 (en) | Process for the preparation of SGLT2 inhibitors and intermediates thereof | |
WO2001056985A1 (fr) | Procede de cyclisation d'acides 4-amino-2-halogenobutyriques optiquement actifs | |
JP4922152B2 (ja) | フッ素化プロリン誘導体の製造方法 | |
WO2016121777A1 (ja) | ピラジンカルボキサミド化合物の製造方法及びその合成中間体 | |
US20120259121A1 (en) | Process for the preparation of montelukast and salts thereof | |
JP6947354B2 (ja) | リナグリプチンの製造法 | |
JP5031778B2 (ja) | 光学活性な2−(アロイルオキシ)プロピオン酸を用いたアミン化合物の製造方法 | |
KR100839322B1 (ko) | B형 간염 치료제 클레부딘의 개선된 제조방법 | |
JP2005509011A (ja) | キラル酒石酸分割剤の回収および再利用 | |
EP1590353B1 (en) | A process for the preparation of cefpodoxime proxetil | |
WO2020129877A1 (ja) | イソキノリンスルホニルクロリド酸付加塩及びその製造方法 | |
EP1251115A1 (en) | Process for producing optically active carboxylic acid substituted in 2-position | |
JP4925518B2 (ja) | 置換アルキルアミン誘導体の製造方法 | |
JP2006022045A (ja) | 光学活性1−t−ブトキシカルボニル−3−アミノピロリジン塩の単離精製方法 | |
JPH11292869A (ja) | イプリフラボンの製法 | |
JP2871556B2 (ja) | プロペノン誘導体及びその製造法 | |
KR100868160B1 (ko) | S-(-)-암로디핀 또는 이의 염의 제조방법 및 이에사용되는 중간체 | |
JP3981996B2 (ja) | ケトオキサゾリジノン及び該化合物からのアミドインダノールの製造法 | |
JP2009019004A (ja) | 光学活性アリールオキシカルボン酸誘導体の製造方法 | |
JPH08208571A (ja) | アミノケトン誘導体のラセミ化方法 | |
JP2004026676A (ja) | ハロゲノ−4−ジヒドロキシメチルピリジン、その製造法及びそれを用いたハロゲノ−4−ピリジンカルバルデヒドの製造法 | |
JP2008260714A (ja) | 光学活性ハロアルコール類の製造方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
ENP | Entry into the national phase |
Ref country code: JP Ref document number: 2001 556835 Kind code of ref document: A Format of ref document f/p: F |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2001902737 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 2001902737 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 10182649 Country of ref document: US |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWG | Wipo information: grant in national office |
Ref document number: 2001902737 Country of ref document: EP |